19 h11 Mendelian Randomization: Opportunities and Challenges of using genetic variants to improve causal inference

 

13 h11 Genetica e terapia del Parkinson 

 

13  h11 Genetica della sclerosi multipla: oltre i GWAS 

 

10 h11 Ghrelin as regulator of muscle mass and muscle regeneration. (related to cancer cachexia and to aging) 

 

15 h11 Caenorhabditis elegans come sistema modello per lo studio delle malattie genetiche

 

11 h11 Epigenetic regulation in human neurodevelopmental disorders 

 

9 h11-17 La genetica di popolazioni nel ricordo di Cavalli-Sforza 

 

15 h11 Genetics of Primary Immunodeficiencies 

 

18 h11 G6PD-Deficiency e favismo

22  h13 Machine Learning Methods in Biology and Medicine 

 

19 h11 Malformazioni dell'arto

 

16 h 11 The mother and the placenta: a matter of allotransplantation 

 

2 h11 Protein archeology: How proteins emerged and evolve? 

 

14 h11 Linfoma B follicolare: una o più entità? Una prospettiva clinica, patologica e genetica

 

16 h11 Il test non invasivo su DNA circolante per la determinazione del rischio di aneuplodie cromosomiche fetali: l'esperienza della SOD Diagnostica Genetica di Firenze 

 

29 h11 Kidney cancer epidemiology from a genomic perspective 

 

18 h 14 Gene Editing as Tools to Explore the Epigenome        

 

10 h11 Drug discovery in Academia

21 h11 Immunogenetics of pregnancy       

 

18 h11 Bioinformatics of High-throughput DNA sequencing

 

16 h11 Targeting SMYD3 to expand the synthetic lethality approach with PARP inhibitors to HR proficient tumors

 

14 h11 Spinal muscular atrophy: from gene to modifier and therapy 

 

15 h13 Covid-19 epidemiological profile: updates

 

29 h11 GdL SIGU Epigenetics DNA methylation and diagnostics

 

23 h 15 Autism spectrum disorder: from gene discovery to functional insights

Silvia De Rubeis

 

Dicembre

22 h11 Roadmap to genome interpretation, from variant-effect prediction to the in-silico diagnosis of genetic disorders

12 h11 Diagnosi genetica preimpianto - PGT: applicazioni e limiti

 

16 h11 Genome-wide risk and its application to prevention in complex diseases

 

16 h11 A phenotype-driven variant prioritization tool for rare disease molecular diagnosis and gene discovery – using Exomiser at scale in the UK 100,000 Genomes Project

 

20 h11 Structural variation in disease and evolution

 

22 h11- Terapia genica e cellulare della Distrofia Muscolare di Duchenne

 

20 h11 Emulating target trials from observational studies

 

26 h11 FOXG1 Control f late neocortical histogeness

 

23 h 11 Post-Mendelian model in COVID-19

 

21 h11 Nuove terapie per difetti congeniti del metabolismo

14 h14 Genetics of complex traits in UK Biobanks

 

15 h11 Genetics of Ataxia